Date of Award
5-2015
Degree Type
Thesis
Degree Name
Departmental Honors
Department
Biology
Abstract
Millions of people die each year from infectious diseases. This is partly due to the difficulty of transporting temperature dependent vaccines through what is called the cold chain in developing countries. I hypothesize that we can increase vaccine accessibility by finding cost effective alternatives to vaccine production and by eliminating the cold chain through vaccine stabilizers. The gold standard in purification of influenza virus is by means of ultracentrifugation. Although effective, this process is very expensive and thus impractical for developing countries. I hypothesize that column chromatography can be a cost efficient alternative that is as effective as ultracentrifugation. The purification ability of column chromatography was tested by comparing two different chromatography resins. The Capto Q resin separates proteins on the basis of protein charge. The Capto 700 resin separates proteins on the basis of both size and charge. It was found that while protein separation occurred, more research will be required to assure full viral protein purification.
It is hypothesized that vaccine stabilizers can be used to eliminate the cold chain. The effect of the gelatin on inactivated influenza virus vaccines was evaluated using hemagglutinin (HA) assays and neuraminidase (NA) assays. The assays evaluate viral protein activity in samples exposed to elevated temperatures for set periods of time (1 min, 5 min, 10 min, 20 min, 40 min, 60 min, 120 min, 240 min, 300 min, and 360 min). Elevated temperatures (45, 52, and 60 degrees Celsius) facilitated an accelerated stability test, which simulates extended effects of time on vaccines. In addition to testing different temperatures, the following concentrations of collagen were used as percent by total volume: 0.3%, 1%, 3%, and 10%. These were tested for optimizing the stabilization of the vaccine. The results of the neuraminidase assay show that 3% collagen significantly increased the stability of the vaccine by approximately 10,000 fold.
Recommended Citation
Madsen, Jorgen, "Increasing Vaccine Accessibility through Cost Alternative Manufacturing and Elimination of the Cold Chain" (2015). Undergraduate Honors Capstone Projects. 268.
https://digitalcommons.usu.edu/honors/268
Included in
Copyright for this work is retained by the student. If you have any questions regarding the inclusion of this work in the Digital Commons, please email us at .
Faculty Mentor
Bart Tarbet